TAVI outcomes in special clinical settings: cancer, diabetes, and frailty

Summary

Delve into the complexities of TAVI outcomes in special clinical populations including patients with cancer, diabetes, and frailty. This session reviews critical analyses and meta-analyses addressing ischemic cerebrovascular events post-TAVI, and compares mortality and post-procedural outcomes between diabetic and non-diabetic patients, providing valuable insights for personalized patient management.

Presentations available when logged in:

  • Clinical outcomes of TAVI in patients with active cancer: a bridge to success?